Crossmark

Establishing Optimal Control Cohorts for Phase 1 Trials: Retrospective Analysis of Clinical and Biological Outcomes in Neonates and Infants Undergoing Two-Ventricle Repair

Crossref DOI link: https://doi.org/10.1007/s00246-024-03550-5

Published Online: 2024-06-25

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kobayashi, Kumi

Kobayashi, Kei

Liu, Christopher

Ryan, Julia

Zurakowski, David

Ishibashi, Nobuyuki
Funding

Funding for this research was provided by:

National Institutes of Health (R33HL146394)

the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program (W81XWH2010199)
License Information

Text and Data Mining valid from 2024-06-25

Version of Record valid from 2024-06-25
More Information

Article History

Received: 2 February 2024

Accepted: 13 June 2024

First Online: 25 June 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below